CEBPZ and acute myeloid leukemia: Of the 31 candidate articles, we excluded two letters to the editor [30, 31], one correspondence [32], one article that focused on relapsed CBF-AML [33], one that did not evaluate prognostic outcomes [34], and three duplicate articles [35–37].